Arcutis Biotherapeutics, Inc. ARQT Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Arcutis Biotherapeutics, Inc. (ARQT) reported operating lease right-of-use assets in other assets of $4.36M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets increased by 136.8% year-over-year, from $1.84M to $4.36M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a 5.9% compound annual growth rate (CAGR), from $3.35M to $4.47M.